English (United States)|Italiano (Italia)
English (United States) | Italiano (Italia)
Dettaglio articolo
ITF PHARMA announces FDA approval of TIGLUTIK™ (riluzole) oral suspension for the tratment of amyotrophic lateral sclerosis (ALS)
Created by superuser on 06/09/2018 14:44:49


print
Sort by: